Position in VTVT
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$1,507
-$12 QoQ
Shares Held
38
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VTVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Parallel Advisors, LLC holds $172,897,730 across 173 Biotechnology names. VTVT ranks #122 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
3,977,404 | $160,329,155 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,522 | $2,465,793 | |
| 3 | RCUS |
Arcus Biosciences, Inc.
|
86,557 | $1,869,631 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,107 | $855,312 | |
| 5 | INCY |
Incyte Corp
|
4,919 | $462,976 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
14,020 | $456,210 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
1,688 | $436,044 | |
| 8 | ARGX |
Argenx SE
|
553 | $403,828 |
All Filings in VTVT
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,507 | 38 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,519 | 38 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $887 | 38 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $570 | 38 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $658 | 38 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $524 | 38 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $515 | 38 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $671 | 38 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $894 | 38 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $437 | 38 | Shares | Sole | 2024-02-12 | |
| No filing history on record for this holder in this stock. | ||||||